Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Multi Asset Allocation median (36 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 20 Mar 2026 – 20 Aug 2026, limited by Capitalmind Multi Asset Allocation Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Capitalmind Multi Asset Allocation Fund | Nifty 50 |
|---|---|---|
| 20 Mar 2026 | ₹100.00 | ₹100.00 |
| 02 Apr 2026 | ₹99.82 | ₹98.26 |
| 15 Apr 2026 | ₹102.14 | ₹104.83 |
| 27 Apr 2026 | ₹102.18 | ₹104.23 |
| 10 May 2026 | ₹102.07 | ₹104.59 |
| 23 May 2026 | ₹102.74 | ₹102.62 |
| 05 Jun 2026 | ₹102.29 | ₹101.09 |
| 17 Jun 2026 | ₹100.78 | ₹104.20 |
| 30 Jun 2026 | ₹97.96 | ₹103.25 |
| 13 Jul 2026 | ₹98.76 | ₹104.74 |
| 26 Jul 2026 | ₹98.80 | ₹102.82 |
| 07 Aug 2026 | ₹101.52 | ₹106.30 |
| 20 Aug 2026 | ₹101.00 | ₹104.83 |
| Metric | Capitalmind · Direct · IDCW NAV ₹10.10 High risk Unrated | Category median Multi Asset Allocation · 36 funds |
|---|---|---|
| — | +13.66% | |
| — | +14.46% | |
| — | +13.79% | |
| — | +9.77% | |
| +1.00% | +13.06% | |
| +0.71% | — | |
| — | +9.80% | |
| — | +9.17% | |
| — | +8.75% | |
| Risk | ||
| 6.82% | 10.17% | |
| — | 0.75 | |
| — | 1.03 | |
| -5.50% | -13.10% | |
| Nifty 50 | — | |
| — | +7.76% | |
| — | 0.63 | |
| — | 83.4% | |
| — | 29.2% | |
| 0.98% | 0.78% | |
| ₹31.48Cr | ₹2,835Cr | |
| 1.00% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹500 | — | |
| 13% | 50% | |
| Anoop Vijaykumar | — | |
| 20 Mar 2026 | — | |
| 29 | — | |
| 26.2% | — | |
| -2.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.